Gribben J G, Vaughan Hudson B, Linch D C
Department of Haematology, University College and Middlesex School of Medicine, London, U.K.
Hematol Oncol. 1987 Oct-Dec;5(4):281-93. doi: 10.1002/hon.2900050406.
Autologous bone marrow transplantation (ABMT) following intensive therapy regimes is being used increasingly in relapsed lymphomas. To date no randomised studies have been performed to ascertain the value of this form of therapy. We describe here our experience of ABMT in both Hodgkin's disease and Non-Hodgkin's Lymphoma and review the situations in which we believe future randomised studies should be based.
强化治疗方案后的自体骨髓移植（ABMT）在复发性淋巴瘤中的应用越来越多。迄今为止，尚未进行随机研究来确定这种治疗形式的价值。我们在此描述我们在霍奇金病和非霍奇金淋巴瘤中进行ABMT的经验，并回顾我们认为未来随机研究应基于的情况。
